Bristol-Myers Squibb entered an agreement to use Concerto HealthAI's machine-learning technology to accelerate clinical trials, develop synthetic control arms, use real-world evidence in regulatory submissions and validate clinical applications for artificial intelligence.
Bristol-Myers Squibb to use AI to speed clinical trials
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.